Is the BRAF V600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer?

American Journal of Surgery

Volumn 203, Issue 4, 2012, Pages 436-441

  Nam, Jung Kwang ^a   Jung, Chan Kwon ^a   Song, Byung Joo ^a   Lim, Dong Jun ^a   Chae, Byung Joo ^a   Lee, Nam Seop ^a   Park, Woo Chan ^a   Kim, Jeong Soo ^a   Jung, Sang Seol ^a   Bae, Ja Seong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

BRAF V600E mutation; Lymph node metastasis; Papillary; Thyroid cancer

Indexed keywords

B TYPE RAF KINASE; DNA; RAF PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RISK; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KOREA; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; POINT MUTATION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS B-RAF; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859099960     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2011.02.013     Document Type: Article

References (25)

1. Y. Ito, H. Yoshida, R. Maruo BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients Endocr J 56 2009 89 97
2. E. Kebebew, J. Weng, J. Bauer The prevalence and prognostic value of BRAF mutation in thyroid cancer Ann Surg 246 2007 466 470
3. E. Kebebew, O.H. Clark Differentiated thyroid cancer: "complete" rational approach World J Surg 24 2000 942 951
4. Y. Ito, T. Uruno, K. Nakano An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid Thyroidology 13 2003 381 387
5. M. Xing BRAF mutation in thyroid cancer Endocr Relat Cancer 12 2005 245 262
6. T.Y. Kim, W.B. Kim, J.Y. Song The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma Clin Endocrinol Oxf 63 2005 588 593
7. T. Fukushima, S. Suzuki, M. Mashiko BRAF mutations in papillary carcinomas of the thyroid Oncogene 22 2003 6455 6457
8. L. Fugazzola, D. Mannavola, V. Cirello BRAF mutations in an Italian cohort of thyroid cancers Clin Endocrinol Oxf 61 2004 239 243
9. M.N. Nikiforova, E.T. Kimura, M. Gandhi BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas J Clin Endocrinol Metab 88 2003 5399 5404
10. C. Lupi, R. Giannini, C. Ugolini Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma J Clin Endocrinol Metab 92 2007 4085 4090
11. M. Schlumberger [Papillary and follicular thyroid carcinoma] Ann Endocrinol (Paris) 68 2007 120 128
12. C. Durante, N. Haddy, E. Baudin Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy J Clin Endocrinol Metab 91 2006 2892 2899
13. G. Riesco-Eizaguirre, P. Gutiérrez-Martnez, M.A. Garca-Cabezas The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I-targeting to the membrane Endocr Relat Cancer 13 2006 257 269
14. D. Fritze, G.M. Doherty Surgical management of cervical lymph nodes in differentiated thyroid cancer Otolaryngol Clin North Am 43 2010 285 300
15. E.A. Garcia, K. Simes, A. Wakamatsu Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions Endocr Pathol 21 2010 101 107
16. H. Davies, G.R. Bignell, C. Cox Mutations of the BRAF gene in human cancer Nature 417 2002 949 954
17. Y. Cohen, M. Xing, E. Mambo BRAF mutation in papillary thyroid carcinoma J Natl Cancer Inst 95 2003 625 627
18. E.T. Kimura, M.N. Nikiforova, Z. Zhu High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma Cancer Res 63 2003 1454 1457
19. K.H. Kim, D.W. Kang, S.H. Kim Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population Yonsei Med J 45 2004 818 821
20. T.G. Kroll Molecular events in follicular thyroid tumors Cancer Treat Res 122 2004 85 105
21. N. Hayashida, H. Namba, A. Kumagai A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells Thyroidology 14 2004 910 915
22. T.J. Giordano, R. Kuick, D.G. Thomas Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis Oncogene 24 2005 6646 6656
23. K.W. Chung, S.K. Yang, G.K. Lee Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area Clin Endocrinol Oxf 65 2006 660 666
24. M. Xing, W.H. Westra, R.P. Tufano BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer J Clin Endocrinol Metab 90 2005 6373 6379
25. V. Trovisco, P. Soares, M. Sobrinho-Simes B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas Hum Pathol 37 2006 781 786